EDGAR Filing Documents for 0001016504-12-000017

Form 8-K - Current report:

SEC Accession No. 0001016504-12-000017

Filing Date

2012-06-29

Accepted

2012-06-29 16:16:37

Documents

Period of Report

2012-06-27

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		inb8k_20120628.htm	8-K	52841
2		exhibit10_1.htm	EX-10.1	1011603
3		exhibit10_2.htm	EX-10.2	36521
4		exhibit10_3.htm	EX-10.3	35823
5		exhibit10_4.htm	EX-10.4	38749
6		exhibit10_5.htm	EX-10.5	39960
7		exhibit10_6.htm	EX-10.6	46849
8		exhibit10_7.htm	EX-10.7	58609
9		exhibit10_8.htm	EX-10.8	143321
10		ex10_8.gif	GRAPHIC	1312
11		exhibit10_9.htm	EX-10.9	128491
12		exhibit10_10.htm	EX-10.10	656322
13		exhibit10_11.htm	EX-10.11	249655
14		exhibit10_12.htm	EX-10.12	134817
15		exhibit10_14.htm	EX-10.14	55843
16		exhibit10_13.htm	EX-10.13	64407
17		exhibit10_15.htm	EX-10.15	73867
18		exhibit99_1.htm	EX-99.1	11669
19		inblogo1.jpg	GRAPHIC	14702
	Complete submission text file	0001016504-12-000017.txt		2863096

Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205

Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816

INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 12936253
SIC: 2834 Pharmaceutical Preparations